心脑血管疾病与微量元素研究进展

心脑血管疾病发病日益增多的原因之一是机体缺乏人体必需微量元素,目前报道硒、锗、锌、钴、铜、锰、铬、钼、钒、镍等与心脑血管疾病有密切关系。用微量元素调控防治心脑血管疾病,目前是国内外研究的新课题,其目的是降低心脑血管疾病的死亡率和发病率,促进人类健康长寿。     

116例冠心病患者血清中铜铬锰钴镍钒含量的探讨

测定了１１６例冠心病患者血清中铜、铬、锰、钴、镍、钒的含量并与正常值比较，显示含量升高才是有铬和镍，降低者有钴和钒、无差异者有铜和锰。     

Electrophoretic Determination of Formaldehyde in Human Urine: Application to Alzheimer’s Disease

The primary clinical diagnosis of Alzheimer’s disease is mainly based on medical history and neuropsychiatric inventory. It is urgent to seek biological indicators with better sensitivity and higher specificity to clinically diagnose and evaluate Alzheimer’s disease. In this work, an electrophoretic method based on 2-thiobarbituric acid derivatization and amperometric detection was developed to determine formaldehyde as a urinary biomarker of Alzheimer’s disease. Under the optimum conditions, the formaldehyde derivative was well separated from the coexisting interferences in urine sample. The limit of detection for formaldehyde was 80.0?nM (2.4?ng/?mL) based on an electrophoretic stacking technology. The average recovery values were in the range of 91.7–110%, and the relative standard deviation values were less than 4.1%. This method has been applied to analyze human urine samples from healthy volunteers and patients with different degrees of Alzheimer’s disease. The assay results showed that the content of urinary formaldehyde in patients suffering Alzheimer’s disease was significantly higher than that in healthy subjects (P?相似文献   

Advanced polymeric dendrimers in the management of Alzheimer's disease

In recent years, advanced polymeric dendrimers have emerged as a promising avenue for AD management. Dendrimers are highly branched, three-dimensional macromolecules with precise nanoarchitectures, making them ideal candidates for the delivery of therapeutic agents and diagnostic tools. Their unique properties, such as well-defined size, multifunctionality, and controlled surface chemistry, allow for the design of targeted and highly efficient drug delivery systems and diagnostic probes. This review aims to provide a comprehensive overview of the potential applications of advanced polymeric dendrimers in the management of Alzheimer's disease. We explored their role in drug delivery, diagnostics, and other therapeutic interventions for AD. Additionally, we will delve into the challenges and opportunities in utilizing dendrimers as a key player in the battle against this devastating disease. The review will begin by discussing the current state of Alzheimer's disease, including its pathological features, clinical manifestations, and existing treatment strategies. It will then transition to an in-depth examination of polymeric dendrimers, highlighting their structural characteristics, synthesis methods, and biocompatibility. Subsequently, the review will delve into the various ways in which dendrimers can be tailored for AD management, including drug encapsulation and delivery, enhanced blood–brain barrier penetration, and targeted diagnostic imaging. Furthermore, we explored the potential benefits of dendrimer-based therapies, such as improved drug efficacy, reduced side effects, and enhanced patient compliance. The review will also address the challenges associated with dendrimer-based approaches, including toxicity concerns, regulatory hurdles, and the need for rigorous clinical evaluation.     

Modifications at the 6-O-position of 1-deoxynojirimycin: facile and efficient synthesis of 6-O-alkylated-N-octyl-1-deoxynojirimycin derivatives

A straightforward synthesis of N-alkylated 1-deoxynojirimycin derivatives modified at the 6-O-position has been described. The key intermediate in the synthesis of target compounds was 2,3,4-tri-O-benzyl-1,5-dideoxy-1,5-imino-D-glucitol, which was prepared from 2,3,4,6-tetra-O-benzyl-1,5-dideoxy-1,5-imino-D-glucitol. Optimal conditions have been established for the synthesis of the key intermediate by varying reaction parameters. Reductive amination and subsequent alkylation of the 6-O-position followed by hydrogenolysis were the main reaction steps, which gave target compounds 6-O-ethyl-N-octyl-1,5-dideoxy-1,5-imino-D-glucitol and 6-O-butyl-N-octyl-1,5-dideoxy-1,5-imino-D-glucitol. This synthetic route is flexible and can be useful for the synthesis of other lipophilic iminosugar derivatives.     

Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson's disease

The aim of this study was to investigate the brain targeting potential of rasagiline-encapsulated chitosan-coated PLGA nanoparticles (RSG-CS-PLGA-NPs) delivered intranasally into the brain. Chitosan-coated PLGA nanoparticles (RSG-CS-PLGA-NPs) were developed through double emulsification-solvent evaporation technique. RSG-CS-PLGA-NPs were characterized for particle size, zeta potential, size distribution, encapsulation efficiency, and in vitro drug release. The mean particle size, polydispersity index, and encapsulation efficiency were found to be 122.38?±?3.64, 0.212?±?0.009, and 75.83?±?3.76, respectively. High-performance liquid chromatography–mass spectroscopy and mass spectroscopy study showed a significantly high mucoadhesive potential of RSG-CS-PLGA-NPs and least for conventional and homogenized nanoformulation. Pharmacokinetic results of RSG-CS-PLGA-NPs in Wistar rat brain and plasma showed a significantly high (**p?<?0.005) AUC_0-24 and amplified C_max over intravenous treatment group. Finally, the investigation demonstrated that intranasal delivery of mucoadhesive nanocarrier showed significant enhancement of bioavailability in brain, after administration of the RSG-CS-PLGA-NPs which could be a substantial achievement of direct nose to brain targeting in Parkinson’s disease therapy and related brain disorders.     

反相高效液相色谱法测定尿中吡啶醚和脱氧吡啶醚

尿中吡啶醚（ｐｙｒｉｄｉｎｏｌｉｎｅ,ＰＹＤ）和脱氧吡啶醚（ｄｅｏｘｙｐｙｒｉｄｉｎｏｌｉｎｅ,ＤＰＤ）是骨代谢特异的生化指标。应用高效液相色谱法（ＨＰＬＣ）建立了尿中ＰＹＤ和ＤＰＤ的测定方法。尿液用６ｍｏｌ／ＬＨＣｌ水解后,以纤维素ＣＦ１小柱提取,然后用ＨＰＬＣ测定;色谱系统为ＳｐｈｅｒｉｓｏｒｂＣ１８反相色谱柱,流动相组成为１５％甲醇添加０．１％七氟丁酸,流速为１．２ｍＬ／ｍｉｎ。系统的检测限：ＰＹＤ为１０ｎｍｏｌ／Ｌ,ＤＰＤ为７ｎｍｏｌ／Ｌ;回收率：ＰＹＤ为９１．５％,ＤＰＤ为１０６．１％;日内变异     

Global exponential stability of a delay reduced SIR model for migrant workers’ home residence

The paper is concerned with a reduced SIR model for migrant workers. By using differential inequality technique and a novel argument, we derive a set of conditions to ensure that the endemic equilibrium of the model is globally exponentially stable. The obtained results complement with some existing ones. We also use numerical simulations to demonstrate the theoretical results.     

miR-130a和miR-125b在川崎病外周血细胞中的表达及意义

目的 通过检测miR-130a 和miR-125b 在伴或不伴冠脉扩张（CAD）川崎病（KD）患儿与正常健康儿童外周血单核细胞（PBMC）中的表达差异,探讨两者可否作为KD 和CAD诊断及预后评估的全新血清生物标志物。方法 利用基因芯片技术筛选出KD 患儿与正常健康儿童之前具有差异表达的miRNAs,通过生物信息学分析,确定候选基因。进一步选取KD 患儿30 例（伴或不伴CAD 各15 例）、正常健康儿童15 例,采用茎环RT-PCR 的方法,验证候选基因miR-130a 和miR-125b 在PBMC 中的表达情况。结果 （1）通过基因芯片技术,分析KD 患儿与正常健康儿童PBMC 中存在明显差异表达的miRNA 共63 条,经过生物信息学分析,确定候选基因;（2）通过茎环RT-PCR 验证发现miR-130a 和miR-125b 在患儿IVIG 治疗前表达明显下调,而IVIG治疗后表达明显上调（P＜0.05）;（3）伴CAD 的KD 患儿miR-130a 及miR-125b 表达较不伴CAD 明显升高,且呈正相关性（R2 =0.734,mir-130a;R2 =0.709,miR-125b）;（4）ROC 曲线分析表明miR-130a（特异度87.5%和敏感度77.5%）和miR-125b（特异度83.3%和敏感度76.6%）对KD 及CAD 的判断有较高的特异度和敏感度。结论 PBMC 中的miR-130a 和miR-125b 参与了KD的发生与发展,可作为KD 及CAD诊断及预后评估的一项全新血清生物标志物,并为KD冠脉扩张的防治提供新的思路。     

Global asymptotic properties of an SEIRS model with multiple infectious stages

The paper presents a rigorous mathematical analysis of a deterministic model, which uses a standard incidence function, for the transmission dynamics of a communicable disease with an arbitrary number of distinct infectious stages. It is shown, using a linear Lyapunov function, that the model has a globally-asymptotically stable disease-free equilibrium whenever the associated reproduction threshold is less than unity. Further, the model has a unique endemic equilibrium when the threshold exceeds unity. The equilibrium is shown to be locally-asymptotically stable, for a special case, using a Krasnoselskii sub-linearity trick. Finally, a non-linear Lyapunov function is used to show the global asymptotic stability of the endemic equilibrium (for the special case). Numerical simulation results, using parameter values relevant to the transmission dynamics of influenza, are presented to illustrate some of the main theoretical results.